A consortium led by global alternative investment manager KKR has agreed to acquire all issued and outstanding shares of Taipei Stock Exchange-listed LCY Chemical for TWD56 (approximately US$1.83) per share and take the company private. The deal values LCY, which produces specialty chemicals for various industries, at TWD47.8 billion (approximately US$1.56 billion). The consortium includes current employees and members of the company’s founding family. KKR, which will invest through KKR Asian Fund III, will hold a controlling stake in LCY. The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the fourth quarter of 2018.